DNA Diagnostic Market

DNA Diagnostics Market is valued at USD 20.88 Billion in 2021 and expected to reach USD 38.41 Billion by 2028 with a CAGR of 9.10% over the forecast period.

Increasing incidences of cancer, rising technological advancements, and growing prevalence of chronic disease are some of the major factors driving the growth of the Global DNA Diagnostics Market.

Scope of Global DNA Diagnostics Market Report-

DNA diagnostics is a technology that allows medical professionals to diagnose many diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for a particular disease. DNA diagnostics is a state-of-the-art technique that is set to revolutionize the field of clinical diagnostics. This technique enables clinicians to differentiate between different diseases such as malignant growths, refractory diseases, and myogenic disorders and to make appropriate decisions for equivalent treatment. It is additionally used for clinical analytical confirmation and prenatal diagnosis.

The Covid-19 pandemic has shown a positive impact on the growth of the global DNA diagnostics market owing to the significant increase of using the DNA diagnostic technology for the development of various drugs and treatments, during the Covid-19 pandemic.

The global DNA diagnostics market is segmented on the product type, technology, application, end-use and region & country level. Based on product type, the global DNA diagnostics market is segmented into DNA diagnostics reagents, DNA diagnostics instruments, and DNA diagnostics software & services. By technology, the global market is segmented into PCR, microarray, mass spectrometry, sequencing technology, and in-situ hybridization. By application, the global DNA diagnostics market is segmented into oncology, pre-implantation, infectious diseases, clinical diagnostic confirmation, and myogenic disorder, prenatal diagnostics, and other. By end-use, the global DNA diagnostics market is segmented into point of care, self-testing/OTC, and diagnostic centers.

The regions covered in the global DNA diagnostics market report are North America, Europe, Asia-Pacific, Latin America, and the rest of the World. Based on country level, the market of global DNA diagnostics is sub divided into U.S., Mexico, Canada, U.K., France, Germany, China, Italy, India, Japan, Southeast Asia, Middle East Asia (Saudi Arabia, UAE, Egypt) GCC, Africa, etc.

Key Players of Global DNA Diagnostics Market Report

Some major key players for the global DNA diagnostics market report cover prominent players like

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Eurofins Scientific
• Hoffmann-La Roche Ltd.
• Genomic Health, Inc.
• Illumina, Inc.
• Myriad Genetics, Inc.
• PerkinElmer, Inc.
• Qiagen N.V.
• Roche Diagnostics
• Siemens Healthineers
• Thermo Fisher Scientific, Inc.
• Others

Global DNA Diagnostics Market Segmentation:

By Product Type

• DNA Diagnostics Reagents
• DNA Diagnostics Instruments
• DNA Diagnostics Software & Services

By Technology

• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• Microarrays
• In Situ Hybridization (ISH)
• DNA Diagnostic Instruments
• Others

By Application

• Oncology
• Infectious Disease
• Genetic Testing
• Forensic Testing
• Prenatal Testing
• Other

By End User

• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Biotechnology Companies
• Others

Report Analysis	Details
Historical data	2018 - 2021
Forecast Period	2022 - 2028
Market Size in 2021:	USD 20.88 Billion
Base year considered	2021
Forecast Period CAGR %:	9.10%
Market Size Expected in 2028:	USD 38.41 Billion
Tables, Charts & Figures:	175
Pages	200
DNA Diagnostic Key Players	Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., Danaher Corporation, Eurofins Scientific, Hoffmann-La Roche Ltd., Genomic Health, Inc., Illumina, Inc., Myriad Genetics, Inc., PerkinElmer, Inc., Qiagen N.V., Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Inc., Others.
Segments Covered	By Product Type, By Technology, By Application, By End-Use
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

News-

Sansure Biotech’s HPV DNA Diagnostic Kit (HPV 13+2) Approved by the NMPA

On January 11th, 2022; Sansure Biotech’s HPV DNA Diagnostic Kit (HPV 13+2) was approved by the China NMPA on January 6th, with reference to the medical device approval released on the NMPA’s official website. This is another blockbuster product from Sansure Biotech in promoting the global elimination of cervical cancer.

Imperial Partnered with DNA Electronics Developed a Breast Cancer Diagnostic Test

On October 27th, 2021; Imperial has partnered with healthcare company DNA Electronics (DNAe) developed a new platform for breast cancer monitoring. The technology is used to bring genomic analysis from specialist laboratories and detect and sequence tumor DNA from blood samples, which could enable earlier detection of recurrent or unresponsive cancers.

Increasing Incidences of Cancer, Rising Technological Advancements, and Growing Prevalence of Chronic Disease are Some of the Major Factors Driving the Market Growth

One of the major factors driving the growth of the DNA diagnostics market is the increasing incidences of cancer. DNA diagnostics help a person gauge their chances of developing cancer in their lifetime. It does this by looking for specific changes in human genes, chromosomes, or proteins. These changes are called mutations. DNA diagnostics are available for some types of cancer. For instance; according to World Health Organization; cancer is the leading cause of death worldwide, with about 10 million deaths in 2020. For people who have already been diagnosed with cancer, DNA diagnostic results can help them make decisions about their treatment and understand their risk of other cancers. Therefore, the increasing prevalence of cancer is expected to fuel the demand for DNA diagnostics. 

In addition, the rising technological advancements are also boosting the growth of the DNA diagnostics market. Technological advancements are also complementing the market growth after developing robust methods such as sequence technology, microarray, novel gene sequencing, myogenic disorders, and others. For instance; as per the news published, on February 10th, 2022; DNA labs launched at-home genetic testing solutions.

Moreover, the growing prevalence of the chronic disease is also supplementing the market growth. For example; according to the Center for Disease Control Gov., on June 17th, 2021; 7 of the top 10 causes of death in the United States are chronic diseases. Six in 10 Americans live with at least one chronic condition, such as stroke, heart disease, cancer, or diabetes.

However, the high cost of reagents associated with DNA diagnostics may hinder the growth of the global DNA diagnostics market. Despite that, the growing adoption of new technologies such as polymerase chain reaction, next-generation sequencing, and microarray, and rising awareness about timely diagnosis may create more opportunities for the further growth of the market. 

North America Holds a Major Share in the Global DNA Diagnostics Market

Geographically, North America is expected to capture a major share in the global DNA diagnostics market within the forecast period due to the increasing prevalence of chronic disease and infectious disease, rising adoption of DNA diagnostics technology, and the presence of key players in this region. The increasing prevalence of chronic disease and infectious disease is driving the growth of the market. For example; according to the Center for Disease Control Gov., on September 17th, 2020; 51.8% of US adults had at least one chronic condition, and 27.2% had multiple chronic conditions. In addition, the rising adoption of DNA diagnostics technology is supplementing the market growth in this region. For instance, as per the news published, on march 7th, 2022; HealthPartners announced a new DNA testing program to detect inheritable diseases.

The Asia Pacific is the fastest-growing region in the global DNA diagnostics market due to improving healthcare infrastructure, rising prevalence of chronic disease, and the rising investment in the research & development activities in this region.

By Regional Analysis

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Key Benefits of Global DNA Diagnostics Market Report

• Global DNA Diagnostics Market report covers in-depth historical and forecast analysis
• Global ;DNA Diagnostics Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global DNA Diagnostics Market report helps to identify opportunities in marketplace.
• Global DNA Diagnostics Market report covers extensive analysis of emerging trends and competitive landscape.